MENU
+Compare
RCEL
Stock ticker: NASDAQ
AS OF
May 13 closing price
Price
$7.01
Change
-$0.24 (-3.31%)
Capitalization
399.48M

RCEL Avita Medical Forecast, Technical & Fundamental Analysis

Avita is a single product company... Show more

RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RCEL with price predictions
May 12, 2025

RCEL in upward trend: price expected to rise as it breaks its lower Bollinger Band on May 09, 2025

RCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where RCEL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for RCEL crossed bullishly above the 50-day moving average on April 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 160 cases where RCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RCEL as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RCEL turned negative on May 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

RCEL moved below its 50-day moving average on May 09, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.143) is normal, around the industry mean (24.179). P/E Ratio (0.000) is within average values for comparable stocks, (79.397). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (7.849) is also within normal values, averaging (42.574).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RCEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
RCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RCEL is expected to report earnings to fall 56.64% to -22 cents per share on August 07

Avita Medical RCEL Stock Earnings Reports
Q2'25
Est.
$-0.23
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.10
Q3'24
Missed
by $0.19
Q2'24
Missed
by $0.12
The last earnings report on May 08 showed earnings per share of -52 cents, missing the estimate of -31 cents. With 498.04K shares outstanding, the current market capitalization sits at 399.48M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
28159 Avenue Stanford
Phone
+1 833 462-8482
Employees
207
Web
https://www.avitamedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

RCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with PHCCF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then PHCCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
+4.02%
PHCCF - RCEL
42%
Loosely correlated
N/A
CVRX - RCEL
33%
Loosely correlated
-0.42%
VREX - RCEL
33%
Loosely correlated
+9.30%
CERS - RCEL
33%
Loosely correlated
+4.65%
SGHT - RCEL
32%
Poorly correlated
+4.22%
More